The RDI was conceived in response to needs, expressed by researchers
and physicians, for more standardized, accurate and reliable methods
of genotypic interpretation and for interpretation based on virological
response rather than phenotype (a measure of viral susceptibility of
drugs derived from growing the virus under artificial conditions in
the laboratory).
The RDI has been established to meet these needs and to 'improve clinical
management of HIV infection' as defined in its mission. In order to
deliver on this mission, the RDI ultimately intends to develop an interpretation
system that will provide estimates of virological response to different
combination treatment options that are derived from virological response
data from clinical practice.
